Autoinjector pen control with AI — the patient activates it alone, so the assembly leaves no room for doubt.
An autoinjector pen is a combination product: the patient will activate it alone, at home, with no second chance. iLEAN Edge sees the assembly part by part, Connect reads the force test bench and the serialization, and the agent builds the FDA (21 CFR Part 4) + MDR file for batch release. The QP signs with evidence.
What the operator can no longer see once the pen is closed is exactly what fails in the patient's home.
An autoinjector pen line brings together two worlds that never quite talk to each other:
- The pharmaceutical side — the prefilled cartridge (typically a PFS or a cartridge) comes out of aseptic packaging with its Annex 1 file, its FMD data, its particle controls. That already exists.
- The device side — the mechanical assembly adds the cap, the spring, the activation mechanism, the dose dial, the secondary label. Every station has its own control, its own sensor, its own PLC. The force and dose test bench is another system. The UDI is printed on yet another.
- PMS feedback — the complaints that arrive after launch (customer service, physicians, pharmacies) live in scattered channels: email, WhatsApp, transcribed calls, web forms.
When a part fails in the patient's home — a cap that stays inside, a partial activation, a dose that is not fully delivered — the problem is reconstructing the story: which batch cohort, which assembly station, which force curve, which intervention. And reconstructing it takes weeks, because every piece of data lives on its own island. The problem is not missing controls — it is that the product's history is split across five systems that never cross-reference each other.
iLEAN does not replace your QMS — it seals the cracks between assembly, the bench and PMS.
The problem is not a lack of controls — it is information living on islands between the pharma side, the device side and market feedback. iLEAN acts as the putty that joins the three stories into one, without asking you to throw away anything you already have — not the pharma MES, not the device QMS, not the customer service system.
Edge sees the assembly part by part. Connect reads the bench and captures PMS. The agent builds the combination product file. The QP signs with continuous evidence.
The three iLEAN pieces applied to the autoinjector pen:
- Edge — terminals with machine vision (CNN) at every critical assembly station: cap presence, correct spring position, UDI reading, final closing. What the operator can no longer see once the pen is closed, Edge verified beforehand. It works with no network. What is critical does not depend on WiFi.
- Connect — captures the force test bench (curves, delivered dose, injection time) whichever way it can, the pharma MES for the cartridge, the assembly SCADA, the UDI/FMD serialization system. And it captures the PMS feedback that arrives by email, WhatsApp and transcribed calls — at second zero, with nobody having to forward anything.
- Agent — cross-references assembly + bench + serial cohort + PMS feedback. If one specific series starts to show a complaint pattern, it flags it. It assembles the batch DHR and the PMS dossier automatically. The three safety rings guarantee that batch release and decisions on deviations stay human.
Combination product on islands vs. one cross-referenced history with iLEAN
| Aspect | Assembly + bench + PMS isolated | With iLEAN Edge + Connect + Agent |
|---|---|---|
| Part-by-part verification | One sensor per station, no cross-referencing | Edge vision cross-referenced with MES and serial |
| Force/dose bench | Separate PDF, filed away | Curve cross-referenced with the batch, evaluated continuously |
| DHR (Device History Record) | Reconstructed by RA, days | Assembled when the batch closes |
| PMS complaints | Scattered across email/WhatsApp/calls | Captured, cross-referenced with the serial cohort |
| Detecting a failure pattern in the market | Weeks | Days — early alert before a recall |
| Operation with no network | n/a | Edge keeps inspecting on the cabinet's own light |
Impact estimate for your plant — to be validated with your numbers.
The block below is an estimate to be validated with the specific data of your plant. We put it forward so RA and the committee have an order of magnitude; we refine it during the diagnostic.
- Plant with an autoinjector pen assembly line, a force/dose test bench, UDI/FMD deployed and customer service on an external system.
- iLEAN Edge pilot (vision over 2-3 critical stations) + Connect (bench + serialization + multichannel PMS). First value expected within a few weeks: the DHR of the first batch assembled automatically.
- DHR reconstruction time cut by ≥ 30%; early alert on complaint patterns in days, not weeks.
- Indicative payback between 4 and 9 months. The hard lever: a single Class III recall avoided or anticipated — plus the recurring RA savings on every release.
And the device quality director's reasonable doubt
“What if the AI decides on its own about a part the patient will activate at home?” — it does not. Edge verifies, Connect captures, the agent cross-references and proposes, the person signs. Hallucination is a problem of free generation, not of anchored tasks: in tasks where the AI judges an image against a validated pattern, the best models brought error below 1.5% [1]. iLEAN's three safety rings guarantee that the critical OT line of the assembly stays isolated from the outside and that the human decision stays exactly where the law says it should.
[1] OpenAI paper “Why Language Models Hallucinate”, 2025 — on the reliability of AI in anchored tasks.
What people ask about autoinjector pen control with AI
What is a combination product and why does it have two sets of rules?
An autoinjector pen is a combination product: the drug (parenteral) and the device (mechanical) reach the patient together. In the EU, EU GMP Annex 1 plus MDR 2017/745 govern the device side; in the US, the FDA applies 21 CFR Part 4 with combined cGMP. That means a single line has to satisfy pharmaceutical process control, medical device validation and serialized traceability at the same time. The data lives in different systems, and the batch record has to cross-reference all of it.
How is the activation force of an autoinjector validated?
With a test bench that measures the force-displacement curve of the spring, the delivered dose and the injection time on AQL samples from the batch. The classic problem: the bench has its own software and its own PDF report, and the data never gets cross-referenced into the pharma MES or into the release file. iLEAN Connect reads the bench whichever way it can (direct integration, local computer, a camera on the panel), and the agent cross-references the curve with the batch recipe and the historical record — if the trend drifts, the QP sees it before release.
Can iLEAN read the test bench of an old autoinjector line?
Yes. iLEAN Connect has three graduated capture modes. If the bench has an API or exports CSV, direct integration. If it only has an isolated local computer, Connect connects to it and extracts the data. If the panel is analog, a camera reads it. It does not force you to replace the bench. The data is tied to the batch at second zero and the agent files it in the batch record, ready for review by the QP and by device R&D/QA.
What do the FDA and EMA require you to document for an autoinjection device?
For the FDA (21 CFR 820 + ISO 13485): a DHR (Device History Record) per batch/serial, evidence of critical inspection, bench calibration, non-conformance records and CAPA. For the EMA (MDR 2017/745 + EU GMP): UDI traceability, manufacturing conformity, post-market surveillance (PMS). iLEAN does not replace your QMS — it feeds the DHR and the PMS file with continuous capture from the plant. What used to be an RA team reconstructing history becomes a dossier already assembled when the batch closes.
How do you anticipate a defect that only shows up in the patient's home?
With Edge vision over the assembly (cap, dose dial, activation mechanism) that sees what the operator can no longer see once the pen is closed, plus cross-referencing with the force test bench. Beyond that: iLEAN Connect captures the PMS feedback that arrives by email, WhatsApp and calls to customer service — and the agent cross-references patterns against the batch cohort. If one specific series starts generating similar complaints, management sees it long before it turns into a Class III recall.
Other related topics: Prefilled syringe with AI · MDI inhaler with AI · Pharma Class III recall with AI.
Tell us your case and in 48h we'll send you the estimated ROI of this AI project for your autoinjector line.
We work on your plant's real data, not ours. Diagnostic with no commitment.
Request estimated ROI in 48h See pharma